In Silico identification of highly conserved CTL epitopes from Streptococcus pyogenes exoenzymes for epitope-based vaccine development
Biomedical Research and Therapy · 28.02.2026 · 13 (02) · 8299-8318
DOI: 10.15419/fkjjvx73 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Research and Therapy, online erschienen am 28.02.2026. Verfasst von Ryanne Pauline S. Chua und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Streptococcus pyogenes represents a major global health concern attributable to its extensive repertoire of virulence factors, which contribute to severe diseases, most notably streptococcal pharyngitis. To facilitate the development of a safer, more targeted vaccine, this study employed a comprehensive in silico immunoinformatics approach to identify highly conserved cytotoxic T-lymphocyte (CTL) epitopes from five critical exoenzymes: SpeB, mitogenic factor (MF), streptolysin O (SLO), streptodornase (DNase), and NAD-glycohydrolase (NADase).
Methods
Conserved sequences were screened using the Protein Variability Server. CTL epitopes were predicted using Immune Epitope Database (IEDB) tools based on MHC class I binding affinity (IC50 500 nM), proteasomal processing, and TAP transport efficiency. Prioritization was given to non-allergenic, non-toxic, and non-cross-reactive epitopes to ensure safety. The selected epitopes were assembled into a multi-epitope vaccine construct, followed by the prediction, refinement, and validation of its secondary and tertiary structures.
Results
Population coverage analysis revealed high global HLA allele representation, with SLO-derived epitopes achieving the broadest worldwide population coverage (91.07%). Molecular docking and thermodynamic analysis validated strong, stable HLA-epitope interactions, with Delta G values ranging from -8.6 to -12. kcal/mol and dissociation constants (KD) ≤ 8.8×10-7M. Secondary structure prediction revealed a stable arrangement with balanced alpha-helices and beta-strands, while tertiary structure modeling and refinement confirmed proper folding and surface accessibility of the epitopes.
Conclusion
These findings highlight SLO, SpeB, and NADase as premier antigenic sources for epitope-based vaccine design. The resulting epitope set demonstrates promising immunogenic potential, safety, and population coverage, necessitating further in vitro and in vivo validation for streptococcal vaccine development.
Zitieren
APA
Chua, R. P. S., Luna, L. M. C., Navarro, P. D. N., Pepito, A. A. M., Sincioco, D. B. A., & Bragais, E. K. B. (2026). In Silico identification of highly conserved CTL epitopes from Streptococcus pyogenes exoenzymes for epitope-based vaccine development. Biomedical Research and Therapy, 13(02), 8299-8318. https://doi.org/10.15419/fkjjvx73
Vancouver
Chua RPS, Luna LMC, Navarro PDN, Pepito AAM, Sincioco DBA, Bragais EKB. In Silico identification of highly conserved CTL epitopes from Streptococcus pyogenes exoenzymes for epitope-based vaccine development. Biomedical Research and Therapy. 2026;13(02):8299-8318. doi:10.15419/fkjjvx73
BibTeX
@article{Chua2026,
author = {Chua, Ryanne Pauline S. and Luna, Louisse Marianne C. and Navarro, Paul Daniel N. and Pepito, Armin Anthony M. and Sincioco, Danielle Bianca A. and Bragais, Edward Kevin B.},
title = {In Silico identification of highly conserved CTL epitopes from Streptococcus pyogenes exoenzymes for epitope-based vaccine development},
journal = {Biomedical Research and Therapy},
year = {2026},
volume = {13},
number = {02},
pages = {8299--8318},
doi = {10.15419/fkjjvx73}
}
EUVIMED